Written by The Organ Preservation Market is gaining momentum as transplant centers adopt technologies designed to preserve organ quality during transportation and improve donor-organ utilization. Market revenue is forecast to increase from USD 382.6 million in 2026 to USD 685.8 million by 2035.
The transition from conventional cold storage toward machine perfusion is one of the most important developments in the industry. Normothermic perfusion allows organs to remain metabolically active and provides an opportunity to assess viability, making the technique particularly valuable for marginal or extended-criteria organs.
The kidney segment leads the market, while liver preservation is among the fastest-growing areas. Heart and lung preservation are also gaining attention as perfusion technologies support donation-after-circulatory-death programs and ex-vivo organ reconditioning.
The market also offers opportunities through ex-vivo organ therapy, AI-supported organ acceptance decisions, outcome-linked service models, and preservation protocols for emerging xenotransplantation applications. These technologies could expand the role of organ preservation beyond simple storage toward active organ assessment and treatment.
Gain valuable insights through comprehensive industry analysis:
Gestational Diabetes Market Trends
Flow Cytometer Reagents Market Growth
Real-World Evidence Market Demand